CAS: 72332-33-3; (R*,S*)-(-)-8-Hydroxy-5-(1-Hydroxy-2-((1-Methylethyl)Amino)Butyl)-2(1H)-Quinolinone

该化合物是一种选择性乙型-2肾上腺素激动剂,主要用作治疗哮喘和慢性阻塞性肺病的支气管.它的作用是刺激气道滑动肌肉中的乙型-2肾上腺受体,导致支气管通过放松和膨胀,从而方便呼吸. 推进剂的特点是行动时间相对较长,适合急性和慢性呼吸条件的管理. 化合物通常通过吸入进行施用,允许有针对性地向肺部交付,同时尽量减少系统性副作用.其化学结构包括苯丙胺和脂性侧链,有助于其药理特性. 与其他乙型-2动物一样,潜在的副作用可能包括激素,热量和心率上升,特别是在较高剂量的情况下.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:WO-9614060-A1
    优先权日:1994-11-04
    标题 :Use of receptor agonists to stimulate superoxide dismutase activity
    发明人:MARKLUND STEFAN L; STRAALIN PONTUS
    权利人:MARKLUND STEFAN L; STRAALIN PONTUS
    摘要:The present invention relates to the use of a substance for the manufacture of a composition for stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells. In particular, the invention relates to the use of a substance for the manufacture of a composition for prophylaxis or treatment of a disease or disorder connected with the presence or formation of superoxide radicals and other toxic intermediates derived from the superoxide radical. Further, the invention relates to a method for determining the effect of a substance with respect to stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells and to substances which have been selected by said method. Within the scope of the invention is a method of preventing, diminishing, controlling or inhibiting a disease or disorder connected with the presence or formation of superoxide radicals and other toxic intermediates derived from the superoxide radical in a patient who has been established to have a high risk of developing a such disease or disorder, or who has developed a such disease or disorder, the method comprising administering an effective amount of a substance which is capable of stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells.

    专利号:US-2025206743-A1
    优先权日:2022-03-25
    标 题:Tyk2 inhibitor synthesis and intermediates thereof
    发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG
    权利人:TAKEDA PHARMACEUTICALS CO
    摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.

    专利号:US-8017776-B2
    优先权日:2003-07-15
    标题 :Methods for synthesis of acyloxyalkyl compounds
    发明人:BHAT LAXMINARAYAN; GALLOP MARK A
    权利人:XENOPORT INC
    摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

    专利号:US-2015158809-A9
    优先权日:2013-02-26
    标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
    发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
    权利人:XENOPORT INC
    摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    This message contains search results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM). Do not reply directly to this message Sent On: Fri Aug 30
    11:22:02 2024 Search: Procaterol From: evan.izzo@medkoo.com 20 selected items Determination of 13 potential anti- obesity agents in hair by dispersive liquid-liquid microextraction-assisted UHPLC-MS/MS. J Pharm Biomed Anal. 2024 Aug 15;246:116236. doi: 10.1016/j.jpba.2024.116236. Epub 2024 May 19.
    703:149685. doi: 10.1016/j.bbrc.2024.149685. Epub 2024 Feb 13. 28(1):8-23. doi: 10.1089/omi.2023.0163. Epub 2024 Jan 8. 13(1):17719. doi: 10.1038/s41598-023-44911-z.
    5: Chen Q, Zhang Y, Sun C, Liu L, Luo X, Wang H, Ni S. Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports. Front Oncol. 2023 Sep 8;13:1282607. doi: 10.3389/fonc.2023.1282607. Erratum for: Front Oncol. 2022 Nov 10;12:1000099. doi: 10.3389/fonc.2022.1000099.

    合成参考文献


    参考文献:10.1159/000092709
    摘要:Ueki S, Usami A, Oyamada H, Saito N, Chiba T, Mahemuti G, Ito W, Kato H, Kayaba H, Chihara J. Procaterol upregulates peroxisome proliferator-activated receptor-gamma expression in human eosinophils. Int Arch Allergy Immunol. 2006;140 Suppl 1():35–41. doi: 10.1159/000092709.
    参考文献:10.1055/s-0031-1296462
    摘要:Shioya T, Satake M, Sato K, Sano MA, Sugawara K, Takahashi H, Honma M. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living. Arzneimittelforschung. 2008;58(1):24–8. doi: 10.1055/s-0031-1296462.
    参考文献:10.1111/j.1476-5381.1985.tb11094.x
    摘要:Göthert M, Hentrich F. Identification of presynaptic β2‐adrenoceptors on the sympathetic nerve fibres of the human pulmonary artery. British J Pharmacology. 1985 Aug;85(4):933–41. doi: 10.1111/j.1476-5381.1985.tb11094.x.
    参考文献:10.1164/arrd.1985.132.6.1194
    摘要:Busse WW, Sharpe G, Smith A, Arbabian M, Borgen L, Ruoho A. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness. Am Rev Respir Dis. 1985 Dec;132(6):1194–8. doi: 10.1164/arrd.1985.132.6.1194.
    参考文献:10.1016/s0022-3565(25)24199-4
    摘要:Fox AW, Juberg EN, May JM, Johnson RD, Abel PW, Minneman KP. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness. The Journal of Pharmacology and Experimental Therapeutics. 1985 Dec;235(3):715–23. doi: 10.1016/s0022-3565(25)24199-4.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知